| Field | Specification |
|---|---|
| Target | |
| Alternative names | Transforming growth factor beta-1;TGF-beta-1;Latency-associated peptide;LAP;Tgfb1; |
| Gene ID | |
| UniProt # | |
| Reactivity | |
| Applications | |
| Immunogen | Expression system for standard: CHO; Immunogen sequence: A279-S390 |
| Expression system | |
| Expression region | |
| Assay type | |
| Sample type(s) | Cell Culture Supernatant, Serum, Plasma, Urine |
| Sensitivity | |
| Detection range | |
| Assay time | |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Assay Principle
This sandwich ELISA quantifies rat transforming growth factor beta-1 proprotein (gene Tgfb1) in cell culture supernatants, serum, plasma (EDTA) and urine. Strips are pre-coated with a capture antibody. After the sample is added, a biotinylated detection antibody binds the captured protein, and an avidin–biotin–peroxidase complex supplies the enzyme. TMB develops color in proportion to the bound target; the reaction is stopped and read at 450 nm, and concentrations are read from the standard curve.
TGF-β1 is the prototypical member of the TGF-β family of cytokines. It is secreted in a latent form held by its latency-associated peptide and, once activated, signals through TGFBR1/TGFBR2 and SMAD proteins to control cell growth, differentiation, extracellular matrix production and immune tolerance, making it central to fibrosis, immunology and cancer research.
Kit Components
| Anti-Rat Tgfb1 Pre-coated 96-well strip microplate | 1 plate (96 wells) |
|---|---|
| Rat Tgfb1 Standard | 2 vials, 10 ng/tube |
| Rat Tgfb1 Biotinylated antibody (100x) | 100 µL |
| Avidin-Biotin-Peroxidase Complex (100x) | 100 µL |
| Sample Diluent | 30 mL |
| Antibody Diluent | 12 mL |
| Avidin-Biotin-Peroxidase Diluent | 12 mL |
| Color Developing Reagent (TMB) | 10 mL |
| Stop Solution | 10 mL |
| Wash Buffer (25x) | 20 mL |
| Adhesive plate sealers | 4 |
Also required (not supplied): microplate reader for 450 nm; incubator; automated plate washer (optional); precision pipettes for 0.5 µL through 1 mL volumes of aqueous solutions; multichannel pipettes (recommended for many samples); deionized or distilled water; 500 mL graduated cylinders; test tubes for dilution.
Kit components are not sold separately.
Performance Data
| Species | Rat |
|---|---|
| Sample types | Cell culture supernatants, serum, plasma (EDTA) and urine |
| Assay range | 15.6 pg/mL–1,000 pg/mL |
| Sensitivity | <1 pg/mL |
| Standard | Recombinant rat Tgfb1 (Ala279–Ser390), expressed in CHO |
| Cross-reactivity | Below 1% cross-reactivity with TGFbeta2, TGFbeta3, TGFbeta5 |
| Intra-assay CV | 5.5–6.1% (3 samples, n = 16 each) |
| Inter-assay CV | 6.2–6.4% (3 samples, n = 24 each) |
| Format | 96 wells, removable strips |
Sample dilution: start at 1:500. In the supplier’s tests, serum and plasma samples measured 24–85 ng/mL.
Example standard curve (OD450, pg/mL): 0 = 0.048; 15.6 = 0.119; 31.2 = 0.177; 62.5 = 0.299; 125 = 0.492; 250 = 0.857; 500 = 1.463; 1000 = 2.223. Run a new standard curve on every plate.
Storage & Handling
Store at 4 °C for up to 6 months or −20 °C for up to 12 months. Avoid repeated freeze–thaw cycles. Ships on gel ice and tolerates up to 3 days at room temperature; freeze on arrival.
Safety
Sample data
| Concentration (pg/ml) | 0 | 15.6 | 31.2 | 62.5 | 125 | 250 | 500 | 1000 |
| O.D. | 0.048 | 0.119 | 0.177 | 0.299 | 0.492 | 0.857 | 1.463 | 2.223 |
Intra/inter assay consistency
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 16 | 16 | 16 | 24 | 24 | 24 |
| Mean (pg/ml) | 27 | 161 | 431 | 28 | 156 | 422 |
| Standard deviation | 1.59 | 9.82 | 23.7 | 1.73 | 9.98 | 26.16 |
| CV (%) | 5.5% | 6.1% | 5.5% | 6.2% | 6.4% | 6.2% |
Kit components
Description|Quantity Pre-coated 96-well strip microplate|1 Standard|2 vials Biotinylated antibody (100x)|100ul Avidin-Biotin-Peroxidase Complex (100x)|100ul Sample Diluent|30ml Antibody Diluent|12ml Avidin-Biotin-Peroxidase Diluent|12ml Color Developing Reagent (TMB)|10ml Stop Solution|10ml Wash Buffer (25x)|20ml Adhesive plate sealers|4Materials required but not provided
- Microplate Reader capable of reading absorbance at 450nm.
- Incubator.
- Automated plate washer (optional).
- Pipettes and pipette tips capable of precisely dispensing 0.5 µl through 1 ml volumes of aqueous solutions.
- Multichannel pipettes are recommended for large amount of samples.
- Deionized or distilled water.
- 500ml graduated cylinders.
- Test tubes for dilution.
Activating reagent preparation
TGF beta 1 is mostly contained as inactive form in samples, please activate it before assay. Don't activate recombinant TGF beta 1.
Solution A: 1N HCI: add 8.33ml of 12N HCI into 91.67ml of H2O.
Solution B: 1.2N NaOH/0.5M HEPES: add 12ml of 10N NaOH and 11.9g HEPES into 75ml of H2O, add H2O to adjust volume to 100ml.
Sample activation procedure
Activate the sample
Cell culture supernatants, urine: add activating reagent pro rata, i.e. add 20μl of Solution A into 100μl of sample, 10 min later, add 20μl of Solution B. PH 7.0-7.6.
Serum, plasma(EDTA): add activating reagent pro rata, i.e. add 20μl of Solution A into 40μl of sample, 10 min later, add 20μl of Solution B. PH 7.0-7.6.
It is unnecessary to activate the recombinant TGFβ 1.
Sample was diluted partly after adding activating reagent, so please pay attention to this when calculate target protein concentration.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Yongyuan Kang et al. (2025) Rod-Shaped Microgel Scaffolds with Interconnective Pores and Oxygen-generating Functions Promote Skin Wound Healing and Alleviate Hypertrophic Scar Formation. Advanced Functional Materials. 10.1002/adfm.202413678
Zimeng Li et al. (2025) Dual-Functional Nanotherapy-Reinforced Hydrogel for Synergistic Antimicrobial and Immunomodulatory Oral Tissue Repair. ACS Nano. 10.1021/acsnano.5c13401
Yan Wang et al. (2020) Multifunctional Supramolecular Hydrogel for Prevention of Epidural Adhesion after Laminectomy. ACS Nano. 10.1021/acsnano.0c01658
Yongyuan Kang et al. (2026) Bifunctional Artificial Enzymes-Loaded Microgels With LOX- and CAT-Like Activities for Metabolic Reprogramming and Scarless Wound Repair. Advanced Science. 10.1002/advs.202521248
Hu Xu et al. (2025) Targeting the E Prostanoid Receptor EP4 Mitigates Cardiac Fibrosis Induced by β-Adrenergic Activation. Advanced Science. 10.1002/advs.202413324
Tong Zhou et al. (2022) A hyaluronic acid/platelet-rich plasma hydrogel containing MnO2 nanozymes efficiently alleviates osteoarthritis in vivo. Carbohydrate Polymers. 10.1016/j.carbpol.2022.119667
Huiwen Hu et al. (2022) Study on repair of abdominal wall defect rats with hernia mesh coated with chitosan-based photosensitive hydrogel. Carbohydrate Polymers. 10.1016/j.carbpol.2022.119577
Jialei Luo et al. (2026) Ultrasound-Responsive Hydrogel with ROS Scavenging and NO Controllable Release Capabilities for Accelerated Healing of Diabetic Wounds. Materials Today Bio. 10.1016/j.mtbio.2026.102796
Lixin Xia et al. (2021) Hemostatic performance of chitosan-based hydrogel and its study on biodistribution and biodegradability in rats. Carbohydrate Polymers. 10.1016/j.carbpol.2021.117965
Liu Tao et al. (2022) Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis. Journal of Translational Medicine. 10.1186/s12967-022-03773-1
